Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2022
DENVER, Aug. 15, 2022 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE:…
Year: 2022
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage…
Zijin Mining Announces 2022 Interim Results: Achieved 89.95% Increase in Net Profit Attributable to Owners
HONG KONG, Aug 16, 2022 – (ACN Newswire) – Zijin Mining Group Co., Ltd. (2899.HK;…
Essex Bio-Technology Included in “Forbes Asia’s Best Under A Billion 2022”
HONG KONG, Aug 16, 2022 – (ACN Newswire) – Essex Bio-Technology Ltd (“EssexBio” or the…
Total Economic Impact Study Reveals Ivanti Neurons for Unified Endpoint Management Solutions Delivered 261% ROI
New study finds Ivanti Neurons for UEM platform delivered benefits of $2.24 million over three…
Healthy Extracts Reports Record Second Quarter 2022, Net Revenue up 93% with Strong Subscription-Based Revenue Growth
LAS VEGAS, Aug. 15, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator…
vTv Therapeutics Announces 2022 Second Quarter Financial Results and Provides Corporate Update
Paul Sekhri appointed as President, Chief Executive Officer and Board member. Entered into agreements with…
Deveron Announces Dates for Q2 2022 Earnings Release
Toronto, Ontario–(Newsfile Corp. – August 15, 2022) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Plurilock Closes First Tranche of Non-Brokered Private Placement of Convertible Debenture Units
Vancouver, British Columbia–(Newsfile Corp. – August 15, 2022) – Plurilock Security Inc. (TSXV: PLUR) (OTCQB:…
Siebert Reports Second Quarter 2022 Financial Results
NEW YORK–(BUSINESS WIRE)–Siebert Financial Corp. (NASDAQ: SIEB) (“Siebert”), a mission-driven provider of financial services, today…
Resverlogix Announces Appointment of New Chief Scientific Officer
CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the…
ABVC BioPharma Reports Second Quarter 2022 Financial and Operational Results
FREMONT, CA, Aug. 15, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (Nasdaq:…
Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) — Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company”…
ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results
TORONTO, Ontario and CAMBRIDGE, Massachusetts, Aug. 15, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX:…
Avicanna Reports Q2 2022 Financial Statement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer
CAMBRIDGE, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”), a…
CinCor Pharma Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
WALTHAM, Mass., Aug. 15, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a…
TransCode Therapeutics Reports Second Quarter 2022 Results; Provides Business Update
BOSTON, Aug. 15, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology…
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
– Enrollment on pace for ongoing pivotal Phase 3 RECOVER trial – – Topline data…
Aileron Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights
Company continues to advance ALRN-6924 as a selective chemoprotective agent for all patients with p53-mutated…